Categories: News

Bota Launches SAION AI — Physical AI Platform for Biomanufacturing

SAN FRANCISCO and HANGZHOU, China, March 10, 2026 /PRNewswire/ — As AI reshapes the digital world through cognitive and generative capabilities, a new frontier emerges: Physical AI — an intelligent system that perceives, reasons through, and acts in the physical world.

- Advertisement -

Today, Bota launches SAION AI, the first Physical AI platform for biomanufacturing.

- Advertisement -

SAION AI is not limited to in silico design. Instead, it is a full-stack Physical AI platform integrating cognition, orchestration, and closed-loop execution through end-to-end experimentation, and continuously optimizing biological discovery and biomanufacturing.

- Advertisement -

SAION AI is built on a three-layer architecture: Cognition, Orchestration, Execution.

- Advertisement -

Powered by large language models , the platform unifies scientific reasoning with real-world experimental execution. This architecture enables seamless orchestration from biological system understanding to laboratory experiments, forming a self-optimizing closed loop for biomanufacturing.

- Advertisement -

Cognition: Multi-Scale Biological Understanding

- Advertisement -

The Cognition Layer is built on data from Bota’s Cell2Cloud Biofoundry, integrating tens of millions of experimental data points, millions of scientific publications and patents, and public biological databases. Combined with leading AI4Science models, SAION AI develops multi-scale understanding across the gene–protein–cell–fermentation continuum, enabling systematic design and data-driven scientific decisions.

- Advertisement -

Orchestration: Intelligent Research Coordination

- Advertisement -

The Orchestration Layer centers on the Agent harness orchestration engine, powered by the LLM reasoning to coordinate multi-agent collaboration, tool invocation, and end-to-end scientific workflows.

- Advertisement -

The Layer decomposes complex objectives into structured tasks and integrates 316 specialized scientific tools, enabling dynamic routing and automated research workflows with fault tolerance.

- Advertisement -

Execution: Autonomous Experimental Operation

- Advertisement -

Through Bota’s proprietary Biological Protocol Language, SAION AI converts experimental designs into standardized instructions that directly drive laboratory hardware, feeding real-world data back into the Cognition Layer, enabling continuous model improvement and R&D acceleration.

- Advertisement -

Real-world Performance

- Advertisement -

SAION AI has demonstrated SOTA performance across multiple life science AI benchmarks, validating its capabilities as an AI Scientist system.

- Advertisement -

Key Results

- Advertisement -
  • Literature Comprehension: 70.7% on LitQA+SuppQA — surpassing leading general-purpose models
  • Sequence Reasoning: 88.2% on SeqQA across DNA, RNA and protein tasks.
  • Genetic Engineering: 84.9% on gene editing and cloning benchmarks.
  • Scientific Discovery: 89.6% on BAIS-SD benchmark.

Real-world validation confirms SAION AI can autonomously complete full research — from literature review to wet-lab assembly — with >90% accuracy.

- Advertisement -

Toward Autonomous Biomanufacturing

- Advertisement -

SAION AI’s launch moves biomanufacturing beyond traditional trial-and-error experimentation toward an intelligent engineering discipline, where AI and physical laboratories interact to accelerate discovery and industrial scale-up.

- Advertisement -

SAION AI DEMO

- Advertisement -

Contact us: bota.pr@bota.bio

- Advertisement -

Photo – https://mma.prnewswire.com/media/2930649/Picture1.jpg

- Advertisement -

Photo – https://mma.prnewswire.com/media/2930650/Picture2.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/bota-launches-saion-ai–physical-ai-platform-for-biomanufacturing-302710125.html

- Advertisement -

Recent Posts

Over 500 Leaders from Across More Than 50 Countries and Territories Attend 56th Annual World Trade Centers Association Global Business Forum in Philadelphia

Flagship WTCA event delivers high-impact sector insights and global business connections across industries NEW YORK,…

10 minutes ago

EquiLend Acquires Finadium, Expanding Presence in Securities Finance Research & Consulting

Finadium to continue operating independently as a subsidiary of EquiLendNEW YORK, May 12, 2026 /PRNewswire/…

10 minutes ago

MEXC Commits to $500M Guardian Fund Expansion, Acquires 1,000 BTC to Strengthen User Protection

VICTORIA, Seychelles, May 12, 2026 /PRNewswire/ -- MEXC, a pioneer in 0-fee digital asset trading,…

10 minutes ago

Maveric Systems announces strategic brand positioning focused on Engineering Trust in AI-First Banking

CHENNAI, India and DALLAS, May 12, 2026 /PRNewswire/ -- Maveric Systems, a banking-exclusive technology specialist,…

10 minutes ago

NYSE Content Update: Disney CEO Josh D’Amaro Rings Bell Ahead of Upfront Event

NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, May 12, 2026…

2 hours ago

Halia Therapeutics to Present Final Phase 2 Ofirnoflast Data in Lower-Risk MDS at EHA2026 and Announces Appointment of Han Myint, MD, FACP, as Chief Medical Officer

European Hematology Association (EHA) oral presentation to report 67% hematological improvement, durable transfusion independence, and…

2 hours ago